How health care is turning into a consumer product

TECH AND health care have a fraught relationship. On January 3rd Elizabeth Holmes, founder of Theranos, a startup that once epitomised the promise of combining Silicon Valley’s dynamism with a stodgy health-care market, was convicted of lying to investors about the capabilities of her firm’s blood-testing technology. Yet look beyond Theranos, which began to implode back in 2015, and a much healthier story becomes apparent. This week a horde of entrepreneurs and investors gathered virtually at the annual JPMorgan Chase health-care jamboree. Top of mind was artificial intelligence (AI), digital diagnostics and tele-health—and of a new wave of capital flooding into a vast industry.